Primary cutaneous acral CD8+ T-cell lymphoma (acral CD8+ TCL) is a rare form of cutaneous T-cell lymphoma characterized clinically by a solitary, slow-growing nodule arising most commonly on the ear. Other peripheral locations such as the nose, hands, and feet can be primary sites. Bilateral, symmetrical presentation has been reported, but multifocal presentation is rare. The solitary nodule most often lacks ulceration.
Acral CD8+ TCL typically presents in adults aged 50 and older, with a median age at diagnosis of 54. Males are more commonly affected than females.
Overall, prognosis of acral CD8+ TCL is excellent with a 5-year survival rate of 100%. It has an indolent course, and no staging investigations have shown progression to systemic disease during follow-up periods of up to 10 years.
Primary cutaneous acral CD8+ T-cell lymphoma
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
C84.A0 – Cutaneous T-cell lymphoma, unspecified, unspecified site
SNOMEDCT:
787198005 – Primary cutaneous acral CD8 positive T-cell lymphoma
C84.A0 – Cutaneous T-cell lymphoma, unspecified, unspecified site
SNOMEDCT:
787198005 – Primary cutaneous acral CD8 positive T-cell lymphoma
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:02/07/2022
Last Updated:02/20/2022
Last Updated:02/20/2022
Primary cutaneous acral CD8+ T-cell lymphoma